GEM-DIMER Trademark

Trademark Overview

On Friday, December 12, 2025, a trademark application was filed for GEM-DIMER with the United States Patent and Trademark Office. The USPTO has given the GEM-DIMER trademark a serial number of 99545865. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, April 29, 2026. This trademark is owned by Hinge Bio, Inc.. The GEM-DIMER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations comprising of monospecific, bispecific, or multi-specific antibody based molecules for the treatment of human diseases, namely, autoimmune, inflammatory, oncologic and neoplastic, infectious, cardiovascular, metabolic, endocrine, respiratory, musculoskeletal, neuromuscular, neurologic, mental health, dermatologic, ophthalmologic, hematologic, renal, gastrointestinal and digestive system, urogenital, reproductive, pediatric and developmental, neurodevelopmental, genetic, rare, namely, chronic, progressive, and life-threatening, and orphan diseases and disorders, conditions related to transplantation and tolerance, and immune mediated conditions; pharmaceutical agents comprising of monospecific, bispecific, or multi-specific antibody based molecules for the treatment of human diseases, namely, autoimmune, inflammatory, oncologic and neoplastic, infectious, cardiovascular, metabolic, endocrine, respiratory, musculoskeletal, neuromuscular, neurologic, mental hea...
gem-dimer

General Information

Serial Number99545865
Word MarkGEM-DIMER
Filing DateFriday, December 12, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, April 29, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations comprising of monospecific, bispecific, or multi-specific antibody based molecules for the treatment of human diseases, namely, autoimmune, inflammatory, oncologic and neoplastic, infectious, cardiovascular, metabolic, endocrine, respiratory, musculoskeletal, neuromuscular, neurologic, mental health, dermatologic, ophthalmologic, hematologic, renal, gastrointestinal and digestive system, urogenital, reproductive, pediatric and developmental, neurodevelopmental, genetic, rare, namely, chronic, progressive, and life-threatening, and orphan diseases and disorders, conditions related to transplantation and tolerance, and immune mediated conditions; pharmaceutical agents comprising of monospecific, bispecific, or multi-specific antibody based molecules for the treatment of human diseases, namely, autoimmune, inflammatory, oncologic and neoplastic, infectious, cardiovascular, metabolic, endocrine, respiratory, musculoskeletal, neuromuscular, neurologic, mental health, dermatologic, ophthalmologic, hematologic, renal, gastrointestinal and digestive system, urogenital, reproductive, pediatric and developmental, neurodevelopmental, genetic, rare, namely, chronic, progressive, and life-threatening, and orphan diseases and disorders, conditions related to transplantation and tolerance, and immune mediated conditions; monospecific, bispecific, or multi-specific antibody based molecules as a component in pharmaceutical preparations for the treatment of human diseases, namely, autoimmune, inflammatory, oncologic and neoplastic, infectious, cardiovascular, metabolic, endocrine, respiratory, musculoskeletal, neuromuscular, neurologic, mental health, dermatologic, ophthalmologic, hematologic, renal, gastrointestinal and digestive system, urogenital, reproductive, pediatric and developmental, neurodevelopmental, genetic, rare, namely, chronic, progressive, and life-threatening, and orphan diseases and disorders, conditions related to transplantation and tolerance, and immune mediated conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 12, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHinge Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065
US

Trademark Events

Event DateEvent Description
Friday, December 12, 2025NEW APPLICATION ENTERED
Friday, December 12, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 12, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, February 10, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 10, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 10, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 16, 2026ASSIGNED TO EXAMINER
Thursday, April 16, 2026NON-FINAL ACTION WRITTEN
Thursday, April 16, 2026NON-FINAL ACTION E-MAILED
Thursday, April 16, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 29, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 29, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 29, 2026TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

dimer namely diseases metabolic infectious neoplastic endocrine oncologic respiratory pharmaceutical conditions